Literature DB >> 313709

Asbestos-associated neoplasms of B cell lineage.

E Kagan, R J Jacobson, K Y Yeung, D J Haidak, G H Nachnani.   

Abstract

Three different neoplasms of B cell lineage, chronic lymphocytic leukemia, immunoglobulin A (IgA) myeloma and immunoglobulin G (IgG) myeloma were detected in three patients who had heavy occupational exposure to asbestos dust. Two of the patients had coexistent pulmonary asbestosis, whereas the third patient had a pleural mesothelioma subsequent to his initial presentation with myeloma. Defective cell-mediated immunity and hyperactivity of B cell function have previously been noted in patients with asbestosis. We suggest the possibility that these asbestos-related immunologic derangements may predispose to the development of immunoproliferative and lymphoproliferative neoplasms, since such tumors have been observed in a variety of other settings, characterized by protracted hyperactivity of the immune system.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 313709     DOI: 10.1016/0002-9343(79)90408-x

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  6 in total

1.  Immune response in shipyard workers with x ray abnormalities consistent with asbestos exposure.

Authors:  H Anton-Culver; B D Culver; T Kurosaki
Journal:  Br J Ind Med       Date:  1988-07

2.  Pulmonary and systemic immunoregulatory changes during the development of experimental asbestosis.

Authors:  M Rola-Pleszczynski; S Gouin; R Bégin
Journal:  Clin Exp Immunol       Date:  1984-11       Impact factor: 4.330

3.  The use of asbestos-cement pipe for public water supply and the incidence of cancer in selected communities in Utah.

Authors:  T D Sadler; W N Rom; J L Lyon; J O Mason
Journal:  J Community Health       Date:  1984

4.  Incidence of cancer and mortality among employees in the asbestos cement industry in Denmark.

Authors:  E Raffn; E Lynge; K Juel; B Korsgaard
Journal:  Br J Ind Med       Date:  1989-02

5.  Asbestos related changes in pulmonary and systemic immune responses--early enhancement followed by inhibition.

Authors:  M Rola-Pleszczynski; I Lemaire; P Sirois; S Massé; R Bégin
Journal:  Clin Exp Immunol       Date:  1982-08       Impact factor: 4.330

6.  Diminished suppressor cell function in patients with asbestosis.

Authors:  H R Gaumer; N J Doll; J Kaimal; M Schuyler; J E Salvaggio
Journal:  Clin Exp Immunol       Date:  1981-04       Impact factor: 4.330

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.